Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vaccine Innovators Convene to Discuss New Technologies

Published: Monday, March 18, 2013
Last Updated: Monday, March 18, 2013
Bookmark and Share
New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VII: From Protein to Product international scientific conference.

Keynote Speaker Dr. Robin Robinson, Deputy Assistant Secretary and Director Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, will lead off the three-day conference with a presentation titled “Flexible Manufacturing & Synthetic Biology Converge Towards New Defense against Threats.”

Leading scientists, business leaders and regulatory agency representatives from around the world are gathered for the scientific conference to exchange information on bringing life-saving vaccines and antibodies to market more quickly through innovative manufacturing processes. At the conference, world-leading scientists will share how these advances significantly impact responsiveness to life-threatening infectious disease epidemics and bioterrorism threats.

The event is hosted by plant-based vaccine production pioneer, Fraunhofer USA Center for Molecular Biotechnology (CMB), located at the Delaware Technology Park in Newark, Delaware, and is conducted in cooperation with the International Association for Biological Standardization (IABS), headquartered in Geneva, Switzerland.

New Advances in Vaccine Production Proven Safe, Efficient and Effective

With the growing global demand for vaccines and other biologics, development of new, alternative production technologies is critical. The latest advancements in protein production include the use of stem cell, insect cell and plant systems.

“Through the conference,” Executive Director, Fraunhofer USA Center for Molecular Biotechnology and member of the conference organizing committee Dr. Yusibov said, “we hope to exchange information about the progress made by these new technologies in the past several years and spur collaboration for additional discoveries among representatives from academic research and the biotechnology and pharmaceutical industries.”

With a focus on getting to market, topics to be discussed during the three-day conference include progress through clinical trials, technology transfer, and regulatory considerations for new technologies.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!